TAKAYASU ARTERITIS
Clinical trials for TAKAYASU ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new TAKAYASU ARTERITIS trials appear
Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare artery disease? upadacitinib shows promise in small trial
Disease control CompletedThis study tested the drug upadacitinib in 12 people with Takayasu arteritis, a rare autoimmune disease that inflames the body's largest artery. All participants had active disease that did not improve with standard treatments. The goal was to see if upadacitinib could help achie…
Matched conditions: TAKAYASU ARTERITIS
Sponsor: Liu Tian • Aim: Disease control
Last updated Jun 23, 2026 19:17 UTC
-
Could a tiny dose of an alcohol addiction drug ease vasculitis symptoms?
Symptom relief CompletedThis study tested whether a low dose of naltrexone, a drug normally used for alcohol dependence, can improve physical health and quality of life in people with vasculitis (a group of rare blood vessel diseases). Sixty adults with different types of vasculitis took either the low …
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 02, 2026 11:57 UTC
-
Surgery may boost survival in rare artery disease
Knowledge-focused CompletedThis study looked at whether surgery helps people with Takayasu arteritis, a rare disease that narrows major arteries. Researchers compared 78 patients who had surgery to those who got only medical care. The goal was to see if surgery lowers the risk of death.
Matched conditions: TAKAYASU ARTERITIS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:56 UTC